Skip to content

    GPT Healthcare Q3 FY26 earnings call

    GPTHEALTH
    Healthcare·3 Feb 2026
    Management Summary

    GPT Healthcare delivered a strong 9MFY26 performance with double-digit revenue growth and stable margins, driven by improved occupancy and strategic service expansion across its mature hospitals. The new Raipur facility is progressing well towards breakeven, and the company remains focused on its 1,000-bed expansion target by 2027 through both organic and inorganic growth opportunities in Eastern India.

    Highlights

    5
    • Revenue from operations for 9MFY26 grew by 12.12% YoY to ₹350.5 crores, demonstrating healthy performance.

    • EBITDA for 9MFY26 was ₹65.1 crores, maintaining a stable operating margin of 18.58%.

    • Salt Lake Hospital's occupancy improved from 58% to 63% in 9MFY26, supported by increased ARPOB and over 750 robot-enabled surgical procedures.

    • Agartala Hospital saw occupancy growth from 47% to 52% and ARPOB growth of almost 9% YoY, with new comprehensive oncology services.

    • The new Raipur facility is ramping up as planned, with EBITDA loss reducing to ₹2.5 crores in Q3 FY26, and is expected to achieve monthly breakeven within 6-8 months.

    Concerns

    3
    • The Raipur facility incurred an EBITDA loss of ₹2.5 crores in Q3 FY26 and ₹10 crores for 9MFY26, impacting overall profitability.

    • Other expenses increased to 45% of sales, primarily due to promotional activities for the new Raipur hospital, though expected to normalize in 6-8 months.

    • Patient numbers from Bangladesh for Agartala Hospital are still not back to pre-issue levels, indicating a lingering external factor.

    What Changed2

    vs Q4 FY26

    Guidance items15 → 11 (-4)Risks discussed4 → 2 (-2)

    Key financials

    Single quarter

    09 metrics
    1. 01Revenue from Operations₹350.5 Cr+12.1%YoY
    2. 02EBITDA₹65.1 Cr
    3. 03EBITDA Margin18.6%
    4. 04PAT₹27.6 Cr
    5. 05PAT Margin7.9%

    Segment breakdown

    Raipur Hospital
    ₹2.5 Cr EBITDA Loss (Q3 FY26)₹10 Cr EBITDA Loss (9MFY26)₹1.5 Cr EBITDA Loss (Q4 FY26 expected)
    Salt Lake Hospital
    63% Occupancy (9MFY26)58% Occupancy (previous period)
    Agartala Hospital
    52% Occupancy (9MFY26)47% Occupancy (previous period)9% ARPOB Growth (YoY)37,000 Rs ARPOB
    Dum Dum Hospital
    65% Occupancy42,396 Rs ARPOB40,880 Rs ARPOB (previous period)9,000 patients Inpatients (current period)8,300 patients Inpatients (previous period)4.3 days Average Length of Stay4.5 days Average Length of Stay (previous period)
    Howrah Hospital
    5% Occupancy Improvement (past 6 months)
    List

    Capital allocation

    1
    medium confidence
    CategoryHeadline
    Capex

    ₹75 crores

    Guidance & targets

    11
    CategoryTargetPriority
    Capacity
    Total bed count
    1,000 beds
    High
    Profitability
    Raipur EBITDA Breakeven (monthly)
    Breakeven
    High
    Profitability
    Raipur EBITDA (full financial year)
    EBITDA positive
    High
    Profitability
    Jamshedpur Hospital EBITDA Loss (during commissioning period)
    ₹3-4 crores
    High
    Occupancy
    Agartala Hospital Occupancy
    70%
    High
    Occupancy
    Howrah Hospital Occupancy
    70%
    High
    Occupancy
    Raipur Hospital Occupancy
    70%
    High
    Occupancy
    Mature Hospitals Occupancy (Dum Dum, Salt Lake)
    70%
    High
    Revenue Growth
    Dum Dum Hospital Revenue Growth
    Double-digit growth
    Medium
    Operating Expenses
    Other Expenses as % of Sales
    Come down
    Medium
    Commissioning
    Jamshedpur Hospital Commissioning
    Commissioned
    High

    What to watch in Q4 FY26

    5

    Raipur Hospital Monthly EBITDA Breakeven

    Within 6-8 months
    Current₹2.5 crores loss in Q3 FY26
    TargetMonthly EBITDA breakeven

    Why it matters

    Achievement of breakeven for the new Raipur facility is crucial for improving overall company profitability.

    We expect it to break even, yes, in the next 6 months on a monthly basis.

    Risks & concerns

    2
    RiskSeverity

    Initial EBITDA Losses from New Raipur Facility

    The Raipur facility incurred an EBITDA loss of ₹2.5 crores in Q3 FY26 and ₹10 crores for 9MFY26, with an additional ₹1.5-2 crores expected in Q4 FY26, impacting overall profitability in the short term.Management acknowledged

    medium

    Lingering Impact of Bangladesh Patient Volume on Agartala Hospital

    While management has redirected marketing efforts, patient numbers from Bangladesh for Agartala Hospital are still not back to previous levels, indicating a persistent external factor affecting patient inflow.Management acknowledged

    low

    Q&A highlights

    8

    “So the Raipur EBITDA loss is around INR 2.5 crores in this quarter. And this has considerably reduced from the previous quarter. ... We expect it to break even, yes, in the next 6 months on a monthly basis.”

    Provides specific financial impact of the new facility and a clear timeline for its profitability, crucial for overall company outlook.

    asked by Sunil Jain

    3 min read6 chapters

    Detailed Narrative

    01

    Robust 9MFY26 Financial Performance

    GPT Healthcare reported a strong financial performance for the nine months ending December 31, 2025, with revenue from operations reaching ₹350.5 crores, marking a healthy year-on-year growth of 12.12%. The company achieved an EBITDA of ₹65.1 crores, translating to a stable operating margin of 18.58%. Profit after tax stood at ₹27.6 crores, with a PAT margin of 7.89%, reflecting effective cost discipline and operational efficiency.

    02

    Operational Efficiencies and Occupancy Growth Across Key Hospitals

    The company's mature facilities demonstrated improved operational metrics. Salt Lake Hospital saw its occupancy increase from 58% to 63% in 9MFY26, supported by a sustained increase in ARPOB and over 750 robot-enabled surgical procedures. Agartala Hospital's occupancy grew from 47% to 52%, with ARPOB increasing by almost 9% YoY, bolstered by the introduction of comprehensive oncology services. Dum Dum Hospital, despite undergoing restructuring, increased its inpatient numbers by 8% and reduced its average length of stay from 4.5 to 4.3 days, while Howrah Hospital also reported improved occupancy and ARPOB.

    03

    Raipur Facility on Track for Breakeven and Strategic Service Expansion

    The ILS Hospital Raipur, a newly commissioned facility, is progressing well in its ramp-up trajectory. The hospital's EBITDA loss reduced to ₹2.5 crores in Q3 FY26, with a total loss of ₹10 crores for 9MFY26. Management expects the facility to achieve monthly EBITDA breakeven within the next 6-8 months and be EBITDA positive for the full financial year. Raipur has expanded its clinical capabilities, initiating renal transplants and planning for liver transplants, supported by advanced equipment and a skilled clinical team.

    04

    Progress Towards 1,000-Bed Vision and Future Expansion

    GPT Healthcare remains committed to its vision of building a 1,000-bedded hospital chain by 2027. The upcoming 150-bed Jamshedpur hospital is firmly on track for commissioning by Q4 FY27, with an earmarked capex of ₹75 crores yet to be spent. The company is actively pursuing and evaluating further expansion opportunities, both brownfield and greenfield, in the eastern part of the country to achieve its long-term capacity targets and strengthen its presence in underserved regions.

    05

    Targeted Occupancy and ARPOB Improvement

    Management has set clear operational targets, aiming for an ideal occupancy rate of 70-75% across its hospitals. Agartala and Howrah hospitals are expected to reach the 70% occupancy mark within the next 1 year, while the Raipur facility is targeted to achieve 70% occupancy within the next 3 years. Mature hospitals like Dum Dum and Salt Lake are also projected to reach the 70% mark within 1.5 years, driven by strategic departmental focus and ARPOB growth, with Dum Dum's ARPOB already increasing to ₹42,000.

    06

    Impact of CGHS and Cost Management

    The company is strategically integrating CGHS patients into its services, currently in Agartala and planned for Raipur, expecting this to be margin accretive due to increased tariffs. Management addressed the increase in 'other expenses,' attributing it primarily to promotional activities for the new Raipur hospital. They anticipate this ratio of other expenses to sales to normalize and come down within the next 6-8 months, contributing to overall margin improvement.

    This is an AI-generated summary of a publicly available earnings call transcript.